¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 3ȸ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ µ¿°è¼ö¼ú½ÉÆ÷Áö¾ö Gynecologic Cancer Surgery Symposium Uterine Corpus Cancer : 2020-01-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦ 3ȸ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ µ¿°è¼ö¼ú½ÉÆ÷Áö¾ö Gynecologic Cancer Surgery Symposium Uterine Corpus Cancer : 2020-01-19
±³À°ÀÏÀÚ : 2020-01-19
±³À°Àå¼Ò : ³ëº¸ÅÚ ¿¥º£¼­´õ ¼­¿ï µ¿´ë¹® ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : Á¦ 3ȸ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ µ¿°è¼ö¼ú½ÉÆ÷Áö¾ö Gynecologic Cancer Surgery Symposium Uterine Corpus Cancer
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÇѼ¼¹Ì
¿¬¶ôó : 02-512-0044  
À̸ÞÀÏ : office@sgo.or.kr      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 01-19 ±×·£µåº¼·ë 08:00~08:50 Registration  () 
±âŸ 01-19 ±×·£µåº¼·ë 08:50~09:00 °³È¸»ç  ±è½Âö(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 09:00~09:30 Radical hysterectomy vs Simple hysterectomy in Stage 2 endometrial cancer  À̱¤¹ü(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 09:30~10:00 Management of uterine sarcoma found incidentally after myomectomy or hysterectomy  Á¤´ëÈÆ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 10:00~10:30 Laparoscopy vs Laparotomy for the management of advanced endometrial cancer  ½Å¼ÒÁø(°è¸íÀÇ´ë) 
Åä·Ð 01-19 ±×·£µåº¼·ë 10:30~10:40 Discussion  () 
È޽Ġ01-19 ±×·£µåº¼·ë 10:40~11:00 COFFEE BREAK  () 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 11:00~11:30 Sentinel lymph node mapping in surgical management of endometrial cancer  ¼ÛÀçÀ±(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 11:30~12:00 Debulking surgery in advanced and recurrent endometrial cancer  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 12:00~12:30 Recent trend in management of uterine carcinosarcoma  ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 01-19 ±×·£µåº¼·ë 12:30~12:40 Discussion  () 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 12:40~13:00 Value of olaparib in BRCA-mutated advanced ovarian cancer  ±è±âµ¿(¼­¿ïÀÇ´ë) 
½Ä»ç 01-19 ±×·£µåº¼·ë 13:00~14:00 LUNCH  () 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 14:00~14:30 Open approach (pelvic)  ±è¿ë¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 14:30~15:00 Open approach (para-arotic)  Àå¼®ÁØ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 15:00~15:30 Laparoscopic approach (multi-port)  ±¸À¯Áø(¿µ³²ÀÇ´ë) 
Åä·Ð 01-19 ±×·£µåº¼·ë 15:30~15:40 Discussion  () 
È޽Ġ01-19 ±×·£µåº¼·ë 15:40~16:00 COFFEE BREAK  () 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 16:00~16:30 Laparoscopic approach (single-port)  ±è»ó¿î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 16:30~17:00 Robotic approach (multi-port)  ¹ÚÁ¤¿­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-19 ±×·£µåº¼·ë 17:00~17:30 Robotic approach (single-port)  À̱ÙÈ£(°¡Å縯ÀÇ´ë) 
±âŸ 01-19 ±×·£µåº¼·ë 17:30~17:40 Æóȸ»ç  ±è½Âö(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 3ȸ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ µ¿°è¼ö¼ú½ÉÆ÷Áö¾ö Gynecologic Cancer Surgery Symposium Uterine Corpus Cancer : 2020-01-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2020³â Á¦8Â÷ ¿¬ÇÏÀå¾Ö Àü¹®Ä¡·á°úÁ¤(±âÃÊ) : 2020-01-19
´ÙÀ½±Û 2020 ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ-´ëÇÑôÃß¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2020-01-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20372 ¼­¿ï ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Á¦ 346Â÷ Áý´ãȸ : 2024-05-28 0 131 2024-04-12
20371 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ(°©»ó¼±¾Èº´Áõ) : 2024-05-28 0 126 2024-04-12
20370 ¼­¿ï International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY2 : 2024-05-28 0 204 2024-04-12
20369 ¼­¿ï International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY 1 : 2024-05-27 0 208 2024-04-12
20368 ¼­¿ï Á¦ 51ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2024-05-26 0 182 2024-04-09
20367 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À°: 2024-05-26 0 191 2024-04-09
20366 ±¤ÁÖ 2024³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° : 2024-05-26 0 164 2024-04-09
20365 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-05-26 0 269 2024-04-09
20364 ¼­¿ï ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-05-26 0 200 2024-04-09
20363 ¼­¿ï 2024³â ´ëÇѼö¸éÇÐȸ Ãá°è±âº»±³À°°­Á : 2024-05-26 0 145 2024-04-09
20362 ±¤ÁÖ Á¦77Â÷ ´ëÇÑÅëÁõÇÐȸ Çмú´ëȸ : 2024-05-25 0 114 2024-04-09
20361 °­¿ø ´ëÇÑ´ç´¢º´ÇÐȸ °­¿øÁöȸ Á¦7ȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2024-05-25 0 184 2024-04-09
20360 ¼­¿ï 2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Adult ADHD ½ÉÆ÷Áö¿ò : 2024-05-24 0 174 2024-04-09
20359 ¼­¿ï ´ëÇѾฮÇÐȸ Frontiers in Epithelial Transport 2024(2ÀÏÂ÷) : 2024-05-24 0 90 2024-04-09
20358 ¼­¿ï Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-05-24 0 146 2024-04-09
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷